Assessing long‐term upgrade risks in recurrent low‐grade non‐muscle‐invasive bladder cancer, can we deintensify the treatment?
BJU International · 2024
DOI: 10.1111/bju.16406 ↗Kurz gefasst
Fachartikel in der Zeitschrift BJU International, 2024. Verfasst von Alessio Finocchiaro und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Science, Humanitas University, Milan, Italy. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 6 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biomedical Science, Humanitas University, Milan, Italy.
- Department of Urology, IRCCS - Humanitas Research Hospital, Milan, Italy.
ORCID-Profile: Marco Paciotti
Zitieren
APA
Finocchiaro, A., Paciotti, M., Contieri, R., Fasulo, V., Saita, A., Lughezzani, G., Buffi, N. M., Lazzeri, M., Hurle, R., & Casale, P. (2024). Assessing long‐term upgrade risks in recurrent low‐grade non‐muscle‐invasive bladder cancer, can we deintensify the treatment?. BJU International. https://doi.org/10.1111/bju.16406
Vancouver
Finocchiaro A, Paciotti M, Contieri R, Fasulo V, Saita A, Lughezzani G, et al. Assessing long‐term upgrade risks in recurrent low‐grade non‐muscle‐invasive bladder cancer, can we deintensify the treatment?. BJU International. 2024. doi:10.1111/bju.16406
BibTeX
@article{Finocchiaro2024,
author = {Finocchiaro, Alessio and Paciotti, Marco and Contieri, Roberto and Fasulo, Vittorio and Saita, Alberto and Lughezzani, Giovanni and Buffi, Nicolo Maria and Lazzeri, Massimo and Hurle, Rodolfo and Casale, Paolo},
title = {Assessing long‐term upgrade risks in recurrent low‐grade non‐muscle‐invasive bladder cancer, can we deintensify the treatment?},
journal = {BJU International},
year = {2024},
doi = {10.1111/bju.16406}
}
EUVIMED